MetLife stock gets a USD 115 Buy target from Jefferies
Jefferies has set a Buy rating and a $115 price target for MetLife stock, which is 21.8% above its October 2, 2026 price of $94.43. This follows Piper Sandler's recent target increase to $110. The company anticipates strong Q3 investment income and reported a 20% rise in Q2 adjusted EPS, contributing to analysts' positive outlook despite the stock being below its yearly high.
MetLife Investment Management closes Galaxy 38 CLO. MetLife stock stays flat
MetLife Investment Management (MIM) announced the closure of Galaxy 38 CLO, Ltd., a new-issue collateralized loan obligation valued at $450 million. Despite this significant financial event, MetLife Inc. (US59156R1086) stock remained flat in weekend trading on October 4, 2026, closing at EUR 84.01. This marks MIM's 45th CLO issuance by its leveraged finance team.
Principal Financial Group, Inc. (PFG) latest stock news and headlines – Yahoo Finance
This Yahoo Finance page provides the latest stock news and headlines for Principal Financial Group, Inc. (PFG). It includes the current stock price, recent performance data, and a list of related articles from various financial news sources covering topics like dividend prospects, valuation, and recent acquisitions. The stock showed a YTD return of +30.07% and a 1-year return of +37.45%, outperforming the S&P 500 in both periods.
3 US Life Insurer Stocks That Could Benefit From Higher Treasury Yields
This article examines three U.S. life insurer stocks—Brighthouse Financial (BHF), Brookfield Wealth Solutions (BNT), and MetLife (MET)—that are well-positioned to benefit from higher Treasury yields. These companies, which rely on long-term bond portfolios and spread income, could see improved profitability as interest rates rise. The analysis highlights how changes in long-term yields, regulation, and product mix could impact their earnings power and overall financial health.
MetLife Investment Management closes CLO: what it means for MetLife stock
MetLife Investment Management announced the closure of Galaxy 38 CLO, Ltd., a $450 million collateralized loan obligation. This marks the 45th CLO issuance by its leveraged finance team. Concurrently, MetLife stock was trading at EUR 84.01 in weekend trading, a slight increase from its previous close.
MET4310085 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the MetLife, Inc. MET4310085 bond, highlighting its key characteristics such as the 4.6% coupon rate and May 2046 maturity date. It includes information on the issuer, issue details, coupon payment schedule, and bond redemption, offering essential metrics for evaluating the bond's potential. The bond, issued by MetLife, Inc., has a face value of $1,000.00 and an outstanding amount of $750 million USD.
MetLife stock after-hours at EUR 84.19: plus 0.32 percent versus prior close
MetLife stock experienced a 0.32 percent increase in after-hours trading, reaching EUR 84.19. This rise followed the announcement of MetLife Investment Management closing its Galaxy 38 CLO with a $450 million target. The article also notes an upcoming investor-relations event for MetLife on September 9, 2026.
MetLife (MET) Stock Forecast and Price Target 2026 $MET
MetLife (MET) currently has a consensus "Buy" rating from 12 Wall Street analysts, with an average 12-month price target of $104.31, suggesting a 10.43% upside from its current price of $94.46. The company recently beat earnings expectations and announced a $3.00 billion share repurchase program, indicating strong financial health. However, it reported lower-than-expected revenue and has seen increasing short interest, highlighting potential challenges.
Brighthouse Financial, Inc. (BHFAM) Stock Price, News, Quote & History
This article provides comprehensive financial data for Brighthouse Financial, Inc. (BHFAM), including its current stock price, historical performance, key financial metrics, and company overview. It highlights the company's offerings in annuity and life insurance products through its various segments, along with recent news and performance trends compared to the S&P 500.
Humana Inc. Research & Ratings | HUM
This article provides research and ratings for Humana Inc. (HUM), including analyst ratings, price targets, stock performance data, and financial estimates. It details the company's segments, key financial figures like EPS and dividend yield, and compares it to peers in the health insurance sector.
MetLife, Inc. (MET) Stock Price, News, Quote & History
This Yahoo Finance page provides comprehensive information on MetLife, Inc. (MET) stock, including its current price, historical data, key statistics, financial overview, and analyst insights. It details MetLife's business segments, product offerings in insurance, annuities, and asset management, and highlights its recent performance metrics and earnings trends.
MetLife, Inc. (MET) stock price, news, quote and history
This article provides a detailed overview of MetLife, Inc. (MET) stock, including its current price, key statistics, historical data, and financial performance. It also includes an analysis of its segments, products, employee count, and analyst insights, such as price targets and recommendations. The content covers financial highlights, recent news, and comparisons with major benchmarks like the S&P 500.
AKC Pet Insurance vs. MetLife Pet Insurance
This article compares AKC Pet Insurance and MetLife Pet Insurance, highlighting their differences in coverage, add-ons, and eligible pet types. AKC Pet Insurance is noted for its extensive add-on options and faster claims processing, while MetLife stands out for covering exotic pets and having no upper age limit for enrollment. The comparison aims to help pet owners choose the best insurance based on their specific needs.
MetLife, Inc. (MET) stock price, news, quote and history
This Yahoo Finance page provides an overview of MetLife, Inc. (MET) stock, including its current price, performance overview, and news. As of October 1, 2026, the stock was trading at $94.35, up 0.20%. MetLife has outperformed the S&P 500 year-to-date and over the past year.
Wall Street Zen upgrades MetLife stock to Buy
Wall Street Zen has upgraded MetLife stock from Hold to Buy. The company estimates at least $600 million in pre-tax variable investment income for Q3 2026 and will release its quarterly earnings report on November 4, 2026. MetLife's stock was trading at EUR 82.83 on October 1, 2026, slightly down from its prior close, and its market capitalization was $60.6 billion as of September 30, 2026.
MetLife stock pre-market at EUR 83.75: plus 0.77 percent
MetLife stock saw a pre-market increase of 0.77 percent at Lang & Schwarz, trading at EUR 83.75 on October 1, 2026. This rise represents a EUR 0.64 jump from its previous close of EUR 83.11 on September 30, 2026. The article also notes an upcoming investor relations event for MetLife at the KBW Annual Insurance Conference on September 9, 2026.
RGA5809108 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the RGA5809108 bond issued by Reinsurance Group of America, Inc. It outlines key facts such as the issuer type, issue and maturity dates, face value, and minimum denomination. The profile also details the bond's interest payments, including a fixed rate of 5.75% paid semi-annually, and redemption information, noting an outstanding amount of $650.00 million USD.
Can Fee-Based Businesses Lift Equitable Holdings' Earnings Mix?
Equitable Holdings, Inc. (EQH) is increasingly focusing on fee-based businesses like Wealth Management and Asset Management to diversify its earnings profile beyond traditional retirement and insurance operations. The company's Wealth Management segment saw significant growth in advisory net inflows and assets under administration in Q2 2026, leading to a rise in adjusted operating earnings. This shift towards recurring asset-based revenues, including through AllianceBernstein, is expected to create a more stable and diversified earnings base, moving away from sole reliance on insurance economics.
MET5615830 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the MetLife, Inc. 5.375% 15-JUL-2033 bond (MET5615830 FINRA). It covers key facts such as the issuer, maturity date, face value, and minimum denomination. The profile also includes information on coupon payments, redemption schedules, and MetLife's business segments.
Prudential Financial Inc preferred stock hits 52-week low at 14.73 USD
Prudential Financial Inc's preferred stock has dropped to a 52-week low of $14.73, marking a 14% decline over the past year. Despite this downturn, an InvestingPro analysis highlights a substantial 6.93% dividend yield. The company recently reported a 14% increase in Q2 2026 adjusted operating income and announced a restructuring plan to improve efficiency.
MetLife Inc Lobbying Profile, 2007
This OpenSecrets profile details MetLife Inc.'s lobbying activities for 2007, showing a total spending of $870,000, all of which was direct lobbying. The data, updated on July 23, 2026, reflects spending from January 1 to June 30 for the most recent year, with prior years covering the full calendar year. The profile is part of OpenSecrets' larger database tracking money in U.S. politics.
MET.IS Bond Profile: Coupon and Redemption
This article provides a detailed profile of the MetLife, Inc. bond (MET.IS) with a 10.75% coupon maturing on August 1, 2039. It outlines key bond facts such as issuer details, issue and maturity dates, face value, and minimum denomination. The profile also covers MetLife's business segments, bond classification, credit risk assessment sections, and a detailed interest payment schedule.
Why Gen X Is Ready to Buy Guaranteed Income
Generation X, having come of age without pensions and enduring multiple market crashes, is increasingly turning to annuities to secure guaranteed lifetime income. Surveys indicate a strong preference among Gen Xers for annuities over stock market investments for windfall money, driven by a desire for financial security in retirement. This trend has led to record annuity sales and prompted the financial industry to focus on providing guaranteed income solutions for this generation.
MetLife stock trades at EUR 84.12 minus 0.08 percent
MetLife stock traded at EUR 84.12 on September 29, 2026, down 0.08 percent from the previous close. The company released a preliminary Q3 variable investment income estimate of at least USD 600 million and reported that its Q2 adjusted EPS rose 20% to USD 2.43. Analysts have an average target price of USD 104.31 for MetLife, with Fitch affirming its ratings as stable.
A3LK3W Bond Profile: Coupon and Redemption
This article provides a detailed profile of the MetLife, Inc. 5.375% 15-JUL-2033 bond (A3LK3W), covering key facts such as issuer information, issue and maturity dates, face value, and minimum denomination. It also outlines MetLife's business segments and details the bond's interest payment schedule, including the coupon rate, frequency, and upcoming payout dates, as well as redemption information.
MetLife stock reports a Q3 income estimate before November results
MetLife Inc. has released a preliminary Q3 variable investment income estimate of at least USD 600 million, ahead of its official earnings report scheduled for November 4, 2026. The stock closed at USD 97.70 on September 25, 2026, which is 3.20 percent below its 52-week high. This estimate provides a key financial checkpoint for investors, even though the final reported income may be influenced by market fluctuations.
MetLife (NYSE:MET) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen has upgraded MetLife (NYSE:MET) stock from a "hold" to a "buy" rating, aligning with other analysts who have also issued "buy" or "overweight" ratings and increased price targets for the company. MetLife recently reported strong quarterly earnings, surpassing analyst estimates, and authorized a $3 billion share repurchase program. The stock's current performance shows it trading near its 12-month high, with a significant portion of its shares owned by institutional investors.
3 Life Insurance Stocks That Could Benefit From Higher Bond Yields
This article identifies three major global life insurance companies—Japan Post Insurance, Brighthouse Financial, and MetLife—that are poised to benefit from rising bond yields. These insurers, with their substantial bond portfolios backing long-term policies, could see improved return profiles as bond markets sell off and government yields approach 20-year highs, despite inflation concerns. The analysis delves into how higher yields could reshape their risk and reward profiles, focusing on their specific operational mixes and market exposures.
MET.JE Bond Profile: Coupon and Redemption
This article provides a detailed profile of the MetLife, Inc. 5.875% 06-FEB-2041 corporate bond (MET.JE). It covers key facts such as issuer information, issue and maturity dates, face value, and a description of MetLife's business segments. The profile also includes details on interest payments, an upcoming coupon payout schedule, and bond redemption information.
MET.GL Bond Profile: Coupon and Redemption
This article provides a detailed profile of the MetLife, Inc. (MET.GL) 6.5% bond maturing on December 15, 2032. It covers key information about the issuer, bond classification, credit risk assessment, interest payment details, and the upcoming coupon payout schedule. The bond has a face value of $1,000.00 USD and pays semi-annual coupons at a fixed rate of 6.50%.
MetLife stock trades at USD 97.25 as Q3 estimate emerges
MetLife's stock traded at USD 97.25 on September 24, 2026, after the insurer provided a preliminary Q3 variable investment income estimate of at least USD 600 million pre-tax. This estimate offers an early indication of Q3 performance ahead of the scheduled results on November 4, 2026. The company also reported strong Q2 2026 earnings, with adjusted EPS up 20% year-over-year, and received an "Overweight" rating from Piper Sandler with a USD 110.00 price target.
MetLife stock heads into the open after Q3 investment update
MetLife stock is reacting to a new third-quarter investment-income update, with the company expecting at least $600 million before tax. This update comes as MetLife executives prepare to participate in the 2026 Keefe, Bruyette and Woods Annual Insurance Conference. The article also notes the S&P 500 closed slightly down on September 24, 2026.
MetLife Q3FY26 Results: Variable investment income guided to $600M
MetLife anticipates its Q3FY26 variable investment income to be at least $600 million pre-tax, contributing significantly to its full-year FY26 guidance of approximately $1.60 billion pre-tax. This quarterly estimate represents nearly 38% of the annual target, highlighting a concentrated performance expectation for the third quarter. The outlook underscores the company's reliance on market-driven returns within its variable product lines.
MET3887852 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the MetLife, Inc. 4.125% 13-AUG-2042 bond (MET3887852). It includes key facts about the issuer, bond classification, credit risk assessment, interest payment details, and redemption information. The bond has a face value of 1,000.00 USD, a semi-annual fixed rate coupon, and an outstanding amount of $750.00 million USD.
MetLife sees Q3 variable investment income at least $600 million pretax
MetLife projects its variable investment income for the third quarter of 2026 to be at least $600 million pre-tax. This preliminary estimate compares to a full-year 2026 guidance of approximately $1.6 billion pre-tax for variable investment income, which includes private equity, real estate, other funds, and prepayment fees. This information was generated by AI based on MetLife's original content filed with the SEC.
MET4969015 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the MetLife, Inc. bond (MET4969015) with a 4.55% coupon maturing on March 23, 2030. It covers key facts about the issuer, bond classification, interest payment details, and upcoming coupon payout schedules. The profile also highlights redemption information, including the outstanding amount of $1.00 billion USD.
UBS AG Prices MetLife-Linked Contingent Income Securities at 100% Issue Price
UBS AG has priced contingent income auto-callable securities linked to MetLife, Inc. common stock at a 100.00% public issue price, with an anticipated maturity around October 5, 2029. The estimated initial value for investors ranges from $944.10 to $974.10, and these securities will not be listed on any exchange. UBS Securities LLC will acquire the securities at a discount and resell them, with the estimated initial value reflecting UBS's internal pricing models and various market factors.
MetLife stock adds 1.0 percent ahead of the open
MetLife stock gained 0.99 percent on the NYSE on September 23, 2026, closing at USD 21.35. The stock opened at USD 21.07 and saw a trading volume of 81,830 shares. This performance was in contrast to the S&P 500, which fell 0.8 percent on the same day.
MetLife Inc. stock outperforms competitors on strong trading day
Shares of MetLife Inc. (MET) rose by 1.33% to $97.20 on a day when the broader stock market, including the S&P 500 Index and Dow Jones Industrial Average, experienced declines. This increase broke a three-day losing streak for the company's stock. The article highlights MetLife's strong performance relative to its competitors during a tough trading session.
MetLife stock holds near USD 96 as analysts turn bullish
MetLife stock (MET) closed at USD 95.92 on September 22, 2026, experiencing a slight decline despite an analyst upgrade to a "Buy" rating. The company reported adjusted EPS of USD 2.43 for Q2 2026, beating estimates, but revenue fell short of forecasts. Analysts have an average price target of USD 105.75, suggesting potential upside from the current trading level.
Why Has MetLife (MET) Returned to the Spotlight?
MetLife (NYSE:MET) has re-entered the market spotlight due to a shifting bond-market environment, which is drawing attention to insurers and their investment portfolios. The company's focus on employee benefits, insurance, and retirement products is particularly relevant in this context. The article suggests that future company announcements will be key to validating the current interest in MetLife.
MetLife stock gains as Piper Sandler raises target to USD 110
Piper Sandler has upgraded MetLife (MET) from Neutral to Overweight and increased its price target from USD 99 to USD 110, causing MetLife stock to gain. The upgrade follows MetLife's second-quarter 2026 adjusted earnings per share of USD 2.43, which surpassed Wall Street expectations, despite revenue missing estimates. The stock closed at USD 79.24 on September 21, 2026.
PRU6517905 Bond Profile — Key Metrics
This article provides a bond profile for Prudential Financial, Inc.'s PRU6517905 bond, detailing its key metrics. The bond has a 5.7% coupon rate and matures on September 15, 2036, with an issue date of September 24, 2026. Prudential Financial, Inc. is described as a company engaged in insurance, investment management, and other financial products and services.
Piper Sandler upgrades MetLife to Overweight, sets $110 price target
Piper Sandler has upgraded MetLife's stock to Overweight, setting a price target of $110, which implies a 13.8% upside from its recent closing price. Analysts highlight MetLife's strong business mix, growth potential in capital-light products, and attractive valuation compared to its industry peers as key reasons for the upgrade.
Can MetLife's Group Benefits Segment Maintain Its Momentum?
MetLife's Group Benefits segment is experiencing strong momentum, with adjusted earnings up 25% year over year in Q2 2026, driven by solid volume growth and improved life underwriting. The segment benefits from a broad portfolio and wide distribution network. While some underwriting benefits may moderate, steady sales and diversified product demand are expected to help maintain this momentum, positioning MetLife favorably against competitors like The Hartford and Aflac.
This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Several Wall Street analysts have upgraded their ratings for key stocks, indicating a bullish outlook. Piper Sandler upgraded MetLife (MET) to Overweight with a $110 price target. Northcoast Research upgraded Brinker International (EAT) to Buy with a $275 price target, and Keybanc upgraded Plexus Corp (PLXS) to Overweight with a $300 price target.
Nykredit A S Invests $11.45 Million in The Hartford Insurance Group, Inc. $HIG
Nykredit A/S recently acquired 86,368 shares of The Hartford Insurance Group, Inc. (NYSE:HIG) for approximately $11.45 million. The Hartford exceeded its Q2 earnings expectations with $3.42 EPS and $7.26 billion in revenue. The company maintains a "Hold" consensus rating from analysts with an average price target of $149.07 and declared a $0.60 quarterly dividend.
618,267 Shares in Unum Group $UNM Bought by Bank of America Corp DE
Bank of America Corp DE recently acquired 618,267 shares of Unum Group (UNM) worth approximately $55.3 million, making it one of several institutional investors increasing their stakes. Unum Group reported strong quarterly earnings, matched analyst estimates, and announced a $1 billion share-repurchase program and an increased quarterly dividend. Despite some insider selling, analysts maintain a "Moderate Buy" consensus for UNM, with the stock trading near its 52-week high.
Learn Why The Bull Case For Unum Group (UNM) Could Change Following $1b Buyback Plan
Unum Group (UNM) has announced a new US$1.0 billion share repurchase authorization and has maintained its A-level financial strength ratings from AM Best. This combination signals management's commitment to capital returns while ensuring balance sheet stability. While the buyback doesn't alter operational challenges like fluctuating claim trends, it reinforces the company's ability to generate cash for shareholder payouts and maintain strong capital generation.
MetLife, Inc. (NYSE:MET) Receives Consensus Rating of "Moderate Buy" from Analysts
MetLife, Inc. (NYSE:MET) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $102.77, exceeding its current share price of $97.08. The company recently surpassed quarterly earnings estimates, reporting $2.43 EPS against a $2.30 consensus, and saw a 10.5% year-over-year revenue increase. Additionally, MetLife announced a $3 billion share repurchase program and a quarterly dividend of $0.5925 per share, representing a 2.4% yield.
